Fundraising FoxMetispharmaceuticals
1 known investors
Find your way into Metispharmaceuticals
Sign up to see every warm intro you have to Metispharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Metispharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Metis Pharmaceuticals (剂泰科技) is a biotech company using AI-driven nanomaterial innovation to develop targeted drug delivery and discovery platforms — including AiLNP for nanoparticle delivery design, AiRNA for mRNA sequence design, and AiTEM for small-molecule formulation design. Its technology enables precise LNP targeting of tissues such as liver, lung, muscle, and immune cells to create therapeutic opportunities for oncology, metabolic, autoimmune, and neurodegenerative diseases.
Founders & leadership
陈(
陈红敏 (Hongmin Chen)Co-founder
赖(
赖才达 (Caida Lai)Co-founder
王(
王文首 (Wenshou Wang)Co-founder
Investors · 1
Frequently asked questions
- What does Metispharmaceuticals do?
- Metis Pharmaceuticals (剂泰科技) is a biotech company using AI-driven nanomaterial innovation to develop targeted drug delivery and discovery platforms — including AiLNP for nanoparticle delivery design, AiRNA for mRNA sequence design, and AiTEM for small-molecule formulation design. Its technology enables precise LNP targeting of tissues such as liver, lung, muscle, and immune cells to create therapeutic opportunities for oncology, metabolic, autoimmune, and neurodegenerative diseases.
- Who founded Metispharmaceuticals?
- Metispharmaceuticals was founded by 陈红敏 (Hongmin Chen), 赖才达 (Caida Lai), 王文首 (Wenshou Wang).
- Who are Metispharmaceuticals's investors?
- Metispharmaceuticals's investors include Monolith Venture Advisory Limited.